Ennov completed the acquisition of Enterprise Technology division from Calyx.

Ennov, a comprehensive software platform provider, completed the acquisition of Enterprise Technology divison from Calyx, an eClinical solutions and services provider. Financial terms were not disclosed. “This acquisition enhances both our capabilities and our international footprint. By combining our expertise, we are better equipped to address the evolving demands of the life sciences sector, serving everything from small biotech firms to major pharmaceutical and medical device companies across the entire product development lifecycle,” Olivier Pâris, Ennov President.